Join us from 08:30am – 09:15am ET on Wednesday October 21 at PRovoke’s Global PR Summit for a session on Creating Value: A Response to COVID-19.

In a 45 minute session and discussion between Executive Vice President, Chief Corporate Affairs Officer, Pfizer Inc. Sally Susman and Global Chairman and CEO, Hill+Knowlton Strategies AnnaMaria DeSalva, we will address the intensive biomedical research effort to solve the COVID pandemic, and how communications and corporate affairs leaders will help restore and build value.

We’ll be exploring:

  1. The role Biopharma is playing – and will continue to play – in the recovery, and importantly how this role can change the industry’s reputation.
  2. Given the vast social contract, how corporate affairs leaders play a principal role in value creation – now more than ever.
  3. What agencies and consultants will need to bring to the table in a post-pandemic world.
  4. How to thrive in today’s context and conditions.

Register for the session now.

Our Speakers:

AnnaMaria DeSalva

AnnaMaria DeSalva is the Global Chairman and CEO of Hill+Knowlton Strategies and Vice Chairman of the board at XPO Logistics, Inc. Now a CEO herself, she has spent the last 15 years advising CEOs and boards of companies undergoing transformation and special situations. 

AnnaMaria is a business leader and corporate affairs expert known for creating step changes in growth and reputation at leading innovative companies and global communications services firms.

Before joining H+K in June 2019, AnnaMaria served as Chief Communications Officer of E.I. du Pont de Nemours & Co. (DuPont) from 2014-2018, and subsequently as a senior advisor to Ed Breen, the CEO of DowDuPont, as he advanced the separation and launch of new independent public companies. Prior to her tenure at DuPont, AnnaMaria held leadership roles in corporate affairs and international affairs for Pfizer and Bristol-Myers Squibb respectively.

AnnaMaria can be found on LinkedIn at

Sally Susman

Sally Susman is Executive Vice President and Chief Corporate Affairs Officer at Pfizer. She is vice chair of The Pfizer Foundation and co-chair of Pfizer’s Political Action Committee. 

Sally leads engagement with all of Pfizer’s external stakeholders overseeing global policy, communications, government relations, investor relations and the Chief Patient Office. Sally also heads the firm’s corporate responsibility group. Before joining Pfizer in 2007, Sally held roles at Estée Lauder Companies and the American Express Company. Earlier in her career, she spent eight years in government service focused on international trade issues. 

Sally serves on the board of WPP plc, a world leader in advertising and marketing based in the U.K. and as co-chair of the board of The International Rescue Committee.

Sally can be found on LinkedIn at